x

Information for patients with UnitedHealthcare or Oxford commercial insurance: Read more before booking an appointment.

Kirk Campbell
Mount Sinai Verified Doctors IconMount Sinai Doctors

Kirk Campbell, MD

Internal Medicine, Nephrology

No Patient Experience Ratings

About Me

Dr. Kirk Campbell is the Irene and Dr. Arthur M. Fishberg Professor of Medicine and Professor of Pharmacological Sciences and inaugural Director of the Mount Sinai Center for Kidney Disease Innovation. The Center integrates multidisciplinary glomerular disease, polycystic kidney disease, onco-nephrology and diabetic kidney disease (DKD) clinical programs into a translational research framework. The goal is to leverage state-of-the-art genomic, bioinformatics and molecular phenotyping technology to identify novel therapeutic targets for drug discovery and biomarker validation while expanding patient registry, biobanking, and clinical trial opportunities. These efforts enhance early detection, prevention, and treatment of kidney disease and its complications while expanding Mount Sinai's precision medicine capabilities.

Dr. Campbell received his medical degree from the University of Connecticut. He completed his internal medicine residency at Yale University before pursuing clinical nephrology and postdoctoral research training at Mount Sinai. Dr. Campbell is the President-elect of the National Kidney Foundation, former President of the New York Society of Nephrology, and a member of the Board of Directors of the Nephcure Foundation. He is the recipient of a Distinguished Leader Award from the American Society of Nephrology ,and an elected member of the American Society for Clinical Investigation. Additionally, Dr. Campbell is an active member of the editorial boards of American Journal of Kidney Disease, Kidney360, Kidney International, Frontiers in Medicine and the American Journal of Physiology – Renal Physiology.

Dr. Campbell is the principal investigator (PI) of Mount Sinai’s Kidney Precision Project Recruitment Site, an NIH-funded initiative to identify new markers and treatment targets for personalized, effective, and safe treatments for kidney diseases. He has been awarded a Harrington Discovery Institute Scholar Innovator grant to advance the development of a promising therapeutic intervention for proteinuric kidney disease.

Language
English
Position
PROFESSOR | Medicine, Nephrology, PROFESSOR | Pharmacological Sciences
Hospital Affiliations
  • The Mount Sinai Hospital
Multi-Disciplinary Training Areas

Development Regeneration and Stem Cells [DRS], Disease Mechanisms and Therapeutics (DMT)